Israeli mask maker Sonovia expects 99% coronavirus success after lab test

Company chief technology officer says reusable anti-viral masks are coated in zinc oxide nanoparticles that destroy bacteria, fungi, and viruses and their material can also be used to make PPE for medical teams and seat covers for public transport
Reuters|
An Israeli company expects a fabric it has developed will be able to neutralize close to 99% of the coronavirus, even after being washed multiple times, following a successful lab test.
  • Follow Ynetnews on Facebook and Twitter

  • Sonovia's reusable anti-viral masks are coated in zinc oxide nanoparticles that destroy bacteria, fungi, and viruses, which it says can help stop the spread of the coronavirus.
    2 View gallery
    The Sonovia face mask said to prevent the spread of coronavirus
    The Sonovia face mask said to prevent the spread of coronavirus
    The Sonovia face mask said to prevent the spread of coronavirus
    (Photo: Sovovia)
    Tests in the Micro spectrum (Weipu Jishu) lab in Shanghai had demonstrated that the washable fabric used in its masks neutralized more than 90% of the coronavirus to which it was exposed, Sonovia said on Monday.
    Liat Goldhammer, Sonovia's chief technology officer, said that in the coming weeks the fabric, which can also be used in textiles for hospitals, protective equipment, and clothing, will be able to neutralize almost 99% of the coronavirus.
    Sonovia says its clients include German manufacturers Bruckner and Weber Ultrasonics, and hospitals in Germany and the United States.
    It is conducting a pilot at Adler Plastic in Italy to use its fabric in vehicles and public transport and is selling its masks online to retail consumers.
    The tests in China were performed in accordance with the international standard for determining the antiviral activity of textile products, Sonovia said in a statement.
    2 View gallery
    אפיק סויסה ושמעון לוי שני החולים הקשים ביותר מהקורונה, יצאו לראשונה מהיחידה לטיפול נמרץ
    אפיק סויסה ושמעון לוי שני החולים הקשים ביותר מהקורונה, יצאו לראשונה מהיחידה לטיפול נמרץ
    Medical teams wearing protective gear entering a coronavirus ward at the Ichilov Medical Center in Tel Aviv
    (Photo: Ichilov PR)
    They follow a test last month on the material at Austria's HygCen medical lab using the Vaccinia virus, which has similar properties to the SARS-COVID family and showed "a good virucidal effect", according to the lab report.
    Sonovia, which is planning to go public on Nasdaq this year, is also awaiting a "significant series of tests in a German government-certified laboratory," Goldhammer said.
    Asaf Levy, Sonovia's vice president for sales and operations, said Ernst & Young is preparing a valuation and the company is talking with U.S. and Asian investors regarding participation in the planned stock market offering.
    Comments
    The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
    ""